Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”

Saved in:
Bibliographic Details
Published in:Rheumatology and therapy. 2020-03, Vol.7 (1), p.215-216
Main Authors: van Leeuwen, Kevin D. B., Bohnen, Arthur M.
Format: Article
Language:English
Subjects:
Allopurinol
Family Medicine
Febuxostat
General Practice
Gout
Internal Medicine
Letter
Medicine
Medicine & Public Health
Orthopedics
Quality of Life Research
RCT
Rheumatology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c558t-fd8db329903966c668ad9aaaa572f09088a59e33ce16f2612aea4c1bbd52feae3
container_end_page 216
container_issue 1
container_start_page 215
container_title Rheumatology and therapy.
container_volume 7
creator van Leeuwen, Kevin D. B.
Bohnen, Arthur M.
description
doi_str_mv 10.1007/s40744-019-00187-2
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4f39e70ad0f9462f912fb7ab8a61df3c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4f39e70ad0f9462f912fb7ab8a61df3c</doaj_id><sourcerecordid>2324912818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-fd8db329903966c668ad9aaaa572f09088a59e33ce16f2612aea4c1bbd52feae3</originalsourceid><addsrcrecordid>eNp9Us1u1DAQjhCIVktfgAOyxIUDAf8kjn1BKgv9kSqQKD9Hy3HGu14l9mInwHLqcyB4uT4JplsWygEfPB7PN994xl9R3Cf4CcG4eZoq3FRViYksMSaiKemtYp8SKUpei-r27tzwveIgpRXOKE45F83dYo8RQRkl1X7xbR6GAfyIgkeXF98P0RvtuzC4r9A9Ri_C1PZQPu-dz96r4EvnLUQXohs36Hycug0KFh1BO30JadQjeg8xTQkd9n1YT9H50CPn0clmDTG7BgZn0HzpPCRA51O7AjMm9NmNSxQi-pBtmEZ0nLfLix_3ijtW9wkOru2seHf08u38pDx7fXw6PzwrTV2LsbSd6FpGpcRMcm5yh7qTOq-6oRZLLISuJTBmgHBLOaEadGVI23Y1taCBzYrTLW8X9Eqtoxt03Kignbq6CHGhdByd6UFVlklosO6wlRWnVhJq20a3QnPSWWYy17Mt13pqB-hMnmzU_Q3SmxHvlmoRPqkGUyJEkwkeXRPE8HGCNKrBJQN9rz2EKan8bVWuKojI0If_QFdhij6PSlHBG0IqJllG0S3KxJBSBLt7DMHql5LUVkkqK0ldKSnXmBUP_m5jl_JbNxnAtoCUQ34B8U_t_9D-BCzj2QE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2867114393</pqid></control><display><type>article</type><title>Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access </source><source>Alma/SFX Local Collection</source><creator>van Leeuwen, Kevin D. B. ; Bohnen, Arthur M.</creator><creatorcontrib>van Leeuwen, Kevin D. B. ; Bohnen, Arthur M.</creatorcontrib><identifier>ISSN: 2198-6576</identifier><identifier>EISSN: 2198-6584</identifier><identifier>DOI: 10.1007/s40744-019-00187-2</identifier><identifier>PMID: 31823214</identifier><language>eng</language><publisher>Cheshire: Springer Healthcare</publisher><subject>Allopurinol ; Family Medicine ; Febuxostat ; General Practice ; Gout ; Internal Medicine ; Letter ; Medicine ; Medicine &amp; Public Health ; Orthopedics ; Quality of Life Research ; RCT ; Rheumatology</subject><ispartof>Rheumatology and therapy., 2020-03, Vol.7 (1), p.215-216</ispartof><rights>The Author(s) 2019</rights><rights>The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c558t-fd8db329903966c668ad9aaaa572f09088a59e33ce16f2612aea4c1bbd52feae3</cites><orcidid>0000-0002-4526-0426</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2867114393/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2867114393?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31823214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Leeuwen, Kevin D. B.</creatorcontrib><creatorcontrib>Bohnen, Arthur M.</creatorcontrib><title>Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”</title><title>Rheumatology and therapy.</title><addtitle>Rheumatol Ther</addtitle><addtitle>Rheumatol Ther</addtitle><subject>Allopurinol</subject><subject>Family Medicine</subject><subject>Febuxostat</subject><subject>General Practice</subject><subject>Gout</subject><subject>Internal Medicine</subject><subject>Letter</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Orthopedics</subject><subject>Quality of Life Research</subject><subject>RCT</subject><subject>Rheumatology</subject><issn>2198-6576</issn><issn>2198-6584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9Us1u1DAQjhCIVktfgAOyxIUDAf8kjn1BKgv9kSqQKD9Hy3HGu14l9mInwHLqcyB4uT4JplsWygEfPB7PN994xl9R3Cf4CcG4eZoq3FRViYksMSaiKemtYp8SKUpei-r27tzwveIgpRXOKE45F83dYo8RQRkl1X7xbR6GAfyIgkeXF98P0RvtuzC4r9A9Ri_C1PZQPu-dz96r4EvnLUQXohs36Hycug0KFh1BO30JadQjeg8xTQkd9n1YT9H50CPn0clmDTG7BgZn0HzpPCRA51O7AjMm9NmNSxQi-pBtmEZ0nLfLix_3ijtW9wkOru2seHf08u38pDx7fXw6PzwrTV2LsbSd6FpGpcRMcm5yh7qTOq-6oRZLLISuJTBmgHBLOaEadGVI23Y1taCBzYrTLW8X9Eqtoxt03Kignbq6CHGhdByd6UFVlklosO6wlRWnVhJq20a3QnPSWWYy17Mt13pqB-hMnmzU_Q3SmxHvlmoRPqkGUyJEkwkeXRPE8HGCNKrBJQN9rz2EKan8bVWuKojI0If_QFdhij6PSlHBG0IqJllG0S3KxJBSBLt7DMHql5LUVkkqK0ldKSnXmBUP_m5jl_JbNxnAtoCUQ34B8U_t_9D-BCzj2QE</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>van Leeuwen, Kevin D. B.</creator><creator>Bohnen, Arthur M.</creator><general>Springer Healthcare</general><general>Springer Nature B.V</general><general>Adis, Springer Healthcare</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4526-0426</orcidid></search><sort><creationdate>20200301</creationdate><title>Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”</title><author>van Leeuwen, Kevin D. B. ; Bohnen, Arthur M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-fd8db329903966c668ad9aaaa572f09088a59e33ce16f2612aea4c1bbd52feae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allopurinol</topic><topic>Family Medicine</topic><topic>Febuxostat</topic><topic>General Practice</topic><topic>Gout</topic><topic>Internal Medicine</topic><topic>Letter</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Orthopedics</topic><topic>Quality of Life Research</topic><topic>RCT</topic><topic>Rheumatology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Leeuwen, Kevin D. B.</creatorcontrib><creatorcontrib>Bohnen, Arthur M.</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Rheumatology and therapy.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Leeuwen, Kevin D. B.</au><au>Bohnen, Arthur M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”</atitle><jtitle>Rheumatology and therapy.</jtitle><stitle>Rheumatol Ther</stitle><addtitle>Rheumatol Ther</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>7</volume><issue>1</issue><spage>215</spage><epage>216</epage><pages>215-216</pages><issn>2198-6576</issn><eissn>2198-6584</eissn><cop>Cheshire</cop><pub>Springer Healthcare</pub><pmid>31823214</pmid><doi>10.1007/s40744-019-00187-2</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-4526-0426</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2198-6576
ispartof Rheumatology and therapy., 2020-03, Vol.7 (1), p.215-216
issn 2198-6576
2198-6584
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4f39e70ad0f9462f912fb7ab8a61df3c
source PubMed (Medline); Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access ; Alma/SFX Local Collection
subjects Allopurinol
Family Medicine
Febuxostat
General Practice
Gout
Internal Medicine
Letter
Medicine
Medicine & Public Health
Orthopedics
Quality of Life Research
RCT
Rheumatology
title Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A16%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment%20on%20%E2%80%9CA%20Randomized,%20Double-Blind,%20Non-inferiority%20Study%20of%20Febuxostat%20Versus%20Allopurinol%20in%20Hyperuricemic%20Chinese%20Subjects%20with%20or%20Without%20Gout%E2%80%9D&rft.jtitle=Rheumatology%20and%20therapy.&rft.au=van%20Leeuwen,%20Kevin%20D.%20B.&rft.date=2020-03-01&rft.volume=7&rft.issue=1&rft.spage=215&rft.epage=216&rft.pages=215-216&rft.issn=2198-6576&rft.eissn=2198-6584&rft_id=info:doi/10.1007/s40744-019-00187-2&rft_dat=%3Cproquest_doaj_%3E2324912818%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c558t-fd8db329903966c668ad9aaaa572f09088a59e33ce16f2612aea4c1bbd52feae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2867114393&rft_id=info:pmid/31823214&rfr_iscdi=true